Rakesh serves on Prescient’s Board as a Non-Executive Director. After earning a degree in Veterinary Medicine, he completed his MS in Immunology and his PhD in Immunology and Oncology at Imperial College School of Medicine in London. He was then recruited by the oncology biotechnology firm Antisoma, which specializes in the development of antibody-based therapeutics for oncology. After working in oncology drug development for more than a decade, Rakesh joined Prescient in 2007. His renowned expertise in the development and commercialization of biologics makes him an extremely valuable asset to our oncology, immunology and biosimilar clients.
Featured
Prescient Intelligence
Discover our portfolio of AI-powered assessments and intelligent tools designed to support better strategic decisions.
News and insights
Featured
Strategy that learns: Rethinking brand planning for a changing environment
Explore why the strongest brand strategies continue beyond annual planning.
Discover The Prescient Pharma Brand Plan Impact Index
Helping senior leaders strengthen strategy and drive better business performance.
The Four Positioning Challenges Every Pharma Launch Team Must Overcome
Discover four positioning challenges that every pharma launch team should address.
Careers
Work with us
If you're looking to stretch your thinking, lead with purpose, and be part of a culture that values curiosity, accountability and trust, you're in the right place.
